Dr. Suhail Qureshi

Dr. Suhail Qureshi is an Additional Director and Unit Head of Medical Oncology at Fortis Hospital, Shalimar Bagh, New Delhi, bringing 11 years of dedicated clinical experience in the diagnosis and treatment of diverse malignancies. He is a highly trained medical oncologist with advanced qualifications from some of India's most respected institutions, including a fellowship in Medical Oncology, Hematology and Bone Marrow Transplantation from Medanta, The Medicity, Gurugram.

Dr. Qureshi's clinical expertise spans the full spectrum of cancer care, from chemotherapy for solid tumors and hematologic malignancies to advanced immunotherapy and molecular targeted therapies. He has specialized training in adjuvant and neoadjuvant chemotherapy, palliative oncology, hormone therapies for breast and prostate cancers, and autologous bone marrow transplantation. His comprehensive approach ensures that each patient receives individualized treatment tailored to their cancer type, stage, and overall health status.

With a patient-centered philosophy, Dr. Qureshi is experienced in managing international patients seeking oncology care from the Gulf region, Africa, and the SAARC countries. He combines evidence-based treatment protocols with compassionate support, making him a trusted choice for families navigating complex cancer diagnoses. His active engagement with international oncology conferences and contributions to peer-reviewed publications demonstrate his commitment to staying current with evolving treatment paradigms.

Fortis Hospital, Shalimar Bagh is a leading tertiary care center in New Delhi, accredited with advanced oncology infrastructure, multimodal imaging, and supportive care facilities. The hospital's international patient services team facilitates seamless coordination for overseas patients, including visa assistance, accommodation guidance, and multilingual support. For international patients choosing treatment in New Delhi, Dr. Qureshi's expertise combined with Fortis's world-class facilities offers comprehensive, accessible cancer care.